HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE
申请人:Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center
公开号:US20140066424A1
公开(公告)日:2014-03-06
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
申请人:The Walter and Eliza Hall Institute of Medical Research
公开号:US20140066621A1
公开(公告)日:2014-03-06
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Heterocyclic modulators of HIF activity for treatment of disease
申请人:Board of Regents, University of Texas System
公开号:US10208059B2
公开(公告)日:2019-02-19
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.